Vincerx Pharma and Oqory reveal merger and cancer drug data
SAN MATEO, Calif. - Vincerx Pharma, Inc. (NASDAQ:VINC), a clinical-stage biopharmaceutical company with a current market capitalization of $2.77 million, and Oqory, Inc. announced promising results ...
stockhead16h
Phase III Trials: It’s crunch time for these ASX health stocks
Several ASX-listed companies are undertaking phase III clinical trials, the critical final stage before potential regulatory ...
Danaher Corporation (DHR) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Conference Call January 29, 2025 8:00 AM ETCompany ParticipantsJohn Bedford - VP of IRRainer Blair ...